K
Kim F. Rhoads
Researcher at Stanford University
Publications - 52
Citations - 1582
Kim F. Rhoads is an academic researcher from Stanford University. The author has contributed to research in topics: Cancer registry & Cancer. The author has an hindex of 21, co-authored 48 publications receiving 1233 citations. Previous affiliations of Kim F. Rhoads include University of California, San Francisco & Cancer Prevention Institute of California.
Papers
More filters
Journal ArticleDOI
Understanding Racial Disparities in Cancer Treatment and Outcomes
TL;DR: For example, a recent report from the Institute of Medicine found that lack Americans have markedly higher cancer-specific ortality rates than members of other racial and ethnic roups as mentioned in this paper.
Journal ArticleDOI
Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes
TL;DR: Investigation of variation in the management of pancreatic cancer among large hospitals in California, USA, specifically to evaluate whether compliance with NCCN guidelines correlates with patient outcomes found relatively poor overall compliance.
Journal ArticleDOI
Lymph node count from neck dissection predicts mortality in head and neck cancer
Vasu Divi,Michelle M. Chen,Brian Nussenbaum,Kim F. Rhoads,Davud Sirjani,F. Christopher Holsinger,J.L. Shah,Wendy Hara +7 more
TL;DR: A significant overall survival advantage is demonstrated in both patients who are clinically node negative and node positive when ≥ 18 LNs are examined after neck dissection, which suggests that LN count is a potential quality metric for neck dissections.
Journal ArticleDOI
A role for Hox A5 in regulating angiogenesis and vascular patterning.
Kim F. Rhoads,Gemma Arderiu,Aubri Charboneau,Scott L. Hansen,William Y. Hoffman,Nancy Boudreau +5 more
TL;DR: The results suggest that restoring Hox A5 expression may provide a novel means to limit breast tumor growth or expansion of hemangiomas.
Journal ArticleDOI
Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic.
Christine Miaskowski,Steven M. Paul,Karin E. Snowberg,Maura Abbott,Hala T. Borno,Susan Chang,Lee-may Chen,Bevin Cohen,Marilyn J. Hammer,Stacey A. Kenfield,Kord M. Kober,Jon D. Levine,Rachel Pozzar,Kim F. Rhoads,Erin L. Van Blarigan,Katherine Van Loon +15 more
TL;DR: Alarmingly high rates of stress and an extraordinarily high symptom burden among cancer patients are identified, exceeding those previously benchmarked in this population and on par with non-cancer patients with PTSD.